{
  "ticker": "JNJ",
  "target_date": "2025-09-02",
  "actual_date": "2025-09-02",
  "collected_at": "2025-12-08T12:13:33.711531",
  "price": {
    "open": 176.35,
    "high": 178.07,
    "low": 175.77,
    "close": 176.93658447265625,
    "volume": 9049000,
    "change_1d_pct": 0.5,
    "change_7d_pct": 0.24,
    "change_30d_pct": 9.13
  },
  "technicals": {
    "rsi_14": 75.19,
    "sma_20": 173.54,
    "sma_50": 164.31,
    "macd": 3.334,
    "macd_signal": 3.696,
    "macd_histogram": -0.362,
    "bb_upper": 179.37,
    "bb_lower": 167.72,
    "price_vs_sma20_pct": 1.96,
    "price_vs_sma50_pct": 7.68,
    "volume_ratio": 1.11
  },
  "fundamentals": {
    "market_cap": 487713603584,
    "pe_ratio": 19.539576,
    "forward_pe": 19.097168,
    "price_to_book": 6.14411,
    "price_to_sales": 5.292663,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.59,
    "pct_from_52w_low": 43.89
  },
  "macro": {
    "spy": {
      "price": 638.5,
      "change_1d_pct": -0.74,
      "change_7d_pct": -0.78
    },
    "vix": {
      "level": 17.17,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.28
    },
    "dollar_index": {
      "level": 98.4
    },
    "gold": {
      "price": 3549.4
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Johnson & Johnson Scores With Heart Pump Breakthrough",
      "source": "Yahoo",
      "datetime": 1756846432,
      "summary": "Clinical trial shows 16% mortality drop as $55 billion expansion plan unfolds",
      "url": "https://finnhub.io/api/news?id=c90f7de9c46844484d198f73b608e0be44e492ca76092ff6a0b90a4f1048f599"
    },
    {
      "headline": "VONV: Well Balanced Value ETF, But Lagging Some Peers",
      "source": "SeekingAlpha",
      "datetime": 1756826067,
      "summary": "Read the latest analysis on Vanguard Russell 1000 Value, and ETF that tracks the Russell 1000 Value Index.",
      "url": "https://finnhub.io/api/news?id=538092aaa36f305485a3b8808220ae8ab955999fb6a707bf58c7ae91eed47d8c"
    },
    {
      "headline": "Glaukos Builds Dual Growth Engines Amid Market Headwinds",
      "source": "Yahoo",
      "datetime": 1756825800,
      "summary": "GKOS raises revenue guidance after record 1H sales, fueled by iDose TR adoption and expanding international glaucoma momentum.",
      "url": "https://finnhub.io/api/news?id=1f8e00f7346eff4cb746a82fc6d604555357227e9739e0c7235338bfefc7ef7a"
    },
    {
      "headline": "Eli Lilly's New Drugs Beyond Mounjaro and Zepbound Boost Sales",
      "source": "Yahoo",
      "datetime": 1756825260,
      "summary": "Eli Lilly's growing lineup beyond Mounjaro and Zepbound, including Omvoh and Jaypirca, is set to fuel revenue growth through 2025.",
      "url": "https://finnhub.io/api/news?id=f7b8a5b03937a6c38486617ec514d6c3f02ebf94ec57448fba034c5c55d8e281"
    },
    {
      "headline": "Nicotine Gum Market Report 2025-2033 | Competitive Analysis of British American Tobacco, Cambrex, GlaxoSmithKline, ITC, Johnson & Johnson, Novartis, Perrigo, Pfizer, and Takeda",
      "source": "Yahoo",
      "datetime": 1756824300,
      "summary": "The nicotine gum market is driven by smoking cessation initiatives and rising health awareness, leading to increased demand for OTC nicotine therapies. Technological advancements enhance product efficacy, and North America leads the market due to health-conscious consumers. Challenges include overco",
      "url": "https://finnhub.io/api/news?id=33c9ebbab7aeb6d59e547832b4b661f2535bd8fb6e6c7545c0a056616208f8ff"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-08-25",
      "description": "xslF345X05/wk-form4_1756163533.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000182/xslF345X05/wk-form4_1756163533.xml"
    },
    {
      "form": "4",
      "date": "2025-08-18",
      "description": "xslF345X05/wk-form4_1755555550.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000180/xslF345X05/wk-form4_1755555550.xml"
    },
    {
      "form": "10-Q",
      "date": "2025-07-24",
      "description": "jnj-20250629.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000178/jnj-20250629.htm"
    },
    {
      "form": "13F-HR",
      "date": "2025-07-22",
      "description": "xslForm13F_X02/primary_doc.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000090445425000367/xslForm13F_X02/primary_doc.xml"
    },
    {
      "form": "4",
      "date": "2025-07-18",
      "description": "xslF345X05/wk-form4_1752869553.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000172/xslF345X05/wk-form4_1752869553.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}